Volitionrx (VNRX) Net Income Growth (1y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | -49.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -49.54% |
| Sep 30, 2025 | 33.19% |
| Jun 30, 2025 | -59.81% |
| Mar 31, 2025 | 34.08% |
| Dec 31, 2024 | 105.91% |
| Sep 30, 2024 | 99.46% |
| Jun 30, 2024 | 100.78% |
| Mar 31, 2024 | 6.80% |
| Dec 31, 2023 | -9,380.53% |
| Sep 30, 2023 | -12,585.14% |
| Jun 30, 2023 | -11,669.50% |
| Mar 31, 2023 | -10,802.19% |
| Dec 31, 2022 | 28.74% |
| Sep 30, 2022 | 53.79% |
| Jun 30, 2022 | 73.13% |
| Mar 31, 2022 | 791.10% |
| Dec 31, 2021 | 207.31% |
| Sep 30, 2021 | 459.81% |
| Jun 30, 2021 | 722.62% |
| Mar 31, 2021 | 100.16% |
| Dec 31, 2020 | 100.63% |
| Sep 30, 2020 | 100.20% |
| Jun 30, 2020 | 100.14% |
| Mar 31, 2020 | -53.44% |
| Dec 31, 2019 | 10.52% |
| Sep 30, 2019 | 6.84% |
| Jun 30, 2019 | 10.91% |
| Jun 30, 2013 | -12.46% |
| Mar 31, 2013 | -13.23% |